Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹31Cr
Rev Gr TTM
Revenue Growth TTM
-5.81%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

INNOVTEC
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -4.6 | -11.2 | -4.3 | -14.0 | -10.9 | -10.0 | -4.3 | -5.0 | -3.6 | -4.5 | -18.4 | 4.6 |
| 37 | 34 | 33 | 30 | 31 | 30 | 31 | 28 | 35 | 29 | 28 | 29 |
Operating Profit Operating ProfitCr |
| 6.1 | 9.7 | 11.0 | 7.6 | 9.6 | 12.2 | 11.6 | 9.2 | -2.9 | 9.5 | 3.5 | 9.5 |
Other Income Other IncomeCr | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| 0 | 1 | 1 | -1 | 0 | 2 | 2 | 0 | -3 | 1 | -1 | 1 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | 115.0 | 80.0 | 207.5 | 38.7 | -40.7 | 52.5 | 20.2 | 133.8 | -2,156.3 | -12.6 | -171.0 | 413.6 |
| 0.7 | 2.6 | 3.5 | -2.0 | 0.5 | 4.4 | 4.4 | 0.7 | -9.8 | 4.0 | -3.8 | 3.5 |
| 0.1 | 0.4 | 0.6 | -0.3 | 0.1 | 0.7 | 0.7 | 0.1 | -1.5 | 0.6 | -0.5 | 0.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| -0.3 | 18.9 | 13.6 | 21.2 | 16.3 | 3.9 | -3.9 | 9.6 | 0.2 | -10.1 | -5.8 | -4.9 |
| 64 | 74 | 78 | 100 | 122 | 128 | 129 | 147 | 147 | 129 | 124 | 121 |
Operating Profit Operating ProfitCr |
| 16.1 | 17.5 | 23.5 | 19.1 | 15.6 | 14.9 | 10.3 | 7.0 | 7.5 | 9.5 | 7.6 | 4.9 |
Other Income Other IncomeCr | 0 | -1 | 2 | -1 | 1 | 3 | 1 | 1 | 2 | 1 | 1 | 1 |
Interest Expense Interest ExpenseCr | 4 | 4 | 7 | 9 | 9 | 11 | 8 | 9 | 6 | 5 | 5 | 4 |
Depreciation DepreciationCr | 5 | 6 | 8 | 10 | 11 | 12 | 10 | 11 | 9 | 7 | 6 | 5 |
| 3 | 5 | 11 | 5 | 4 | 3 | -3 | -8 | -1 | 2 | 0 | -2 |
| 0 | 1 | 2 | 2 | 2 | 1 | -1 | 0 | 0 | 0 | 0 | 0 |
|
| 82.3 | 1.8 | 167.7 | -65.0 | -16.2 | -24.9 | -213.7 | -225.9 | 80.8 | 224.9 | -101.0 | -10,618.2 |
| 4.4 | 3.8 | 8.9 | 2.6 | 1.9 | 1.3 | -1.6 | -4.7 | -0.9 | 1.3 | 0.0 | -1.5 |
| 1.5 | 1.6 | 4.3 | 1.5 | 1.2 | 0.9 | -1.0 | -3.3 | -0.6 | 0.8 | 0.0 | -0.9 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 24 | 27 | 36 | 39 | 42 | 43 | 40 | 33 | 32 | 33 | 33 | 34 |
Current Liabilities Current LiabilitiesCr | 23 | 22 | 33 | 40 | 52 | 53 | 57 | 48 | 45 | 45 | 24 | 40 |
Non Current Liabilities Non Current LiabilitiesCr | 9 | 28 | 28 | 23 | 20 | 23 | 30 | 32 | 28 | 20 | 24 | 10 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 29 | 24 | 36 | 33 | 43 | 51 | 55 | 49 | 49 | 50 | 40 | 45 |
Non Current Assets Non Current AssetsCr | 29 | 55 | 63 | 71 | 74 | 70 | 75 | 66 | 57 | 51 | 44 | 41 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 21 | 36 | 6 | 22 | 7 | 14 | 5 |
Investing Cash Flow Investing Cash FlowCr | -16 | -11 | -8 | -5 | 0 | 0 | 2 |
Financing Cash Flow Financing Cash FlowCr | -4 | -23 | 0 | -17 | -7 | -12 | -9 |
|
Free Cash Flow Free Cash FlowCr | 0 | 24 | -3 | 17 | 6 | 14 | 6 |
| 783.2 | 1,778.8 | -259.6 | -294.2 | -460.9 | 793.3 | -30,239.8 |
CFO To EBITDA CFO To EBITDA% | 93.2 | 159.5 | 40.1 | 196.5 | 55.7 | 104.5 | 53.9 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 94 | 72 | 144 | 152 | 64 | 19 | 42 | 40 | 33 | 52 | 51 |
Price To Earnings Price To Earnings | 28.4 | 21.7 | 15.8 | 47.6 | 23.9 | 9.5 | 0.0 | 0.0 | 0.0 | 29.1 | 0.0 |
Price To Sales Price To Sales | 1.2 | 0.8 | 1.4 | 1.2 | 0.4 | 0.1 | 0.3 | 0.3 | 0.2 | 0.4 | 0.4 |
Price To Book Price To Book | 3.6 | 2.5 | 3.8 | 3.7 | 1.5 | 0.4 | 1.0 | 1.1 | 1.0 | 1.5 | 1.4 |
| 8.5 | 6.0 | 7.1 | 7.6 | 4.1 | 1.5 | 5.8 | 6.7 | 5.6 | 5.7 | 7.3 |
Profitability Ratios Profitability Ratios |
| 41.6 | 40.1 | 46.6 | 46.5 | 40.8 | 44.6 | 40.2 | 34.6 | 33.5 | 37.9 | 39.6 |
| 16.1 | 17.5 | 23.5 | 19.1 | 15.6 | 14.9 | 10.3 | 7.0 | 7.5 | 9.5 | 7.6 |
| 4.4 | 3.8 | 8.9 | 2.6 | 1.9 | 1.3 | -1.6 | -4.7 | -0.9 | 1.3 | 0.0 |
| 17.8 | 15.9 | 25.9 | 19.1 | 16.8 | 20.5 | 6.0 | 0.9 | 6.9 | 10.8 | 7.3 |
| 12.9 | 11.8 | 23.9 | 7.8 | 6.1 | 4.5 | -5.3 | -21.1 | -4.2 | 5.0 | -0.1 |
| 5.8 | 4.3 | 9.2 | 3.1 | 2.3 | 1.7 | -1.8 | -6.5 | -1.3 | 1.8 | 0.0 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Innovative Tech Pack Limited (**ITPL**) is a pioneering Indian manufacturer specializing in high-quality plastic packaging solutions. The company operates a single-segment business model focused on the production and reselling of **Plastic Bottles, Jars, Containers, Preforms, Caps, Closures, and Dispensers**. Utilizing advanced materials such as **PET, PP, HDPE, and PCTA**, ITPL serves as a critical supply chain partner for leading conglomerates in the FMCG, food and beverage, and pharmaceutical sectors.
---
### **Strategic Manufacturing Footprint and Market Expansion**
ITPL operates **four** strategically located manufacturing facilities designed to minimize logistics costs and facilitate **Just-in-Time (JIT)** inventory management for its clients.
| Plant | Location | Regional Focus |
| :--- | :--- | :--- |
| **Plant 1** | Rudrapur, Uttarakhand | Northern India |
| **Plant 2** | Baddi, Himachal Pradesh | Northern India |
| **Plant 3** | Guwahati, Assam | Eastern India |
| **Plant 4** | IMT Manesar, Haryana | Northern India |
* **Infrastructure:** The facilities are equipped with **40 top-of-the-line machines** sourced from global manufacturers, supported by air-conditioned production rooms and a dedicated **R&D innovation centre**.
* **Geographic Growth:** To penetrate the **Southern Indian** market, the company is currently planning a new manufacturing facility on the **Eastern Coast**.
* **Quality & Compliance:** All plants are **ISO: 22000-2005** certified. The company recently achieved **SEDEX certification** and is pursuing **BRC certification** to deepen its penetration into the high-margin food and pharmaceutical segments.
---
### **Product Portfolio and Material Specialization**
The company’s core competency lies in **Polyethylene terephthalate (PET)**, a sustainable and high-performance thermoplastic. ITPL positions PET as a superior alternative to traditional materials like glass, PP, and PVC.
* **Sustainability Advantage:** ITPL’s products are **environment-friendly** and are not categorized as single-use plastics; they can be **recycled repeatedly**, reducing long-term environmental impact and manufacturing costs.
* **Market Positioning:** The company operates within a global PET volume market of approximately **2 crore tons per annum**.
**Comparative Material Advantages:**
| Feature | PET (ITPL Focus) | PP / HDPE / PVC |
| :--- | :--- | :--- |
| **Weight** | **Lightweight** | Generally heavier |
| **Clarity** | **Transparent** | Often opaque/translucent |
| **Chemical Nature** | **Non-reactive** | Potential reactivity with contents |
| **Cost Profile** | **Cost-effective** | Higher processing costs |
| **Durability** | **High** | Variable |
---
### **Blue-Chip Client Base**
ITPL maintains long-term, stable relationships with several of India’s largest consumer goods and healthcare companies, including:
* **FMCG & Personal Care:** Marico, Wipro Consumer Care, Godrej Consumer Product Limited, Dabur India Limited.
* **Food & Beverage:** Mother Dairy, Bisleri, Perfetti Van Melle India, Heinz India.
* **Ayurvedic/Pharma:** Patanjali Ayurvedic / Divya Pharmacy.
---
### **Turnaround Strategy and Operational Modernization**
ITPL is currently executing a comprehensive turnaround plan to transition from a loss-making entity to a profitable one.
* **Technological Absorption:** The company utilizes technology from **Japanese and French collaborators** and has indigenously developed moulds to mitigate **foreign exchange** risks.
* **Efficiency Drivers:** Management is implementing **automated machines** to lower power consumption and reduce reliance on manual labor.
* **Financial Deleveraging:** A primary strategic pillar is the **reduction of debt burden** to lower finance costs and the aggressive optimization of **working capital**.
* **Cost Discipline:** The company is focused on reducing **non-essential administrative costs** to remain competitive in a "cut-throat" pricing environment.
---
### **Capital Structure and Debt Profile**
As of **September 2023**, the company’s financial liabilities totaled **₹6,920.51 Lakhs**.
| Financial Liability (Amortised Cost) | Amount (₹ in Lakhs) |
| :--- | :--- |
| **Borrowings** | **3,755.21** |
| **Trade Payables** | **3,069.84** |
| **Other Financial Liabilities** | **95.46** |
| **Total Financial Liabilities** | **6,920.51** |
* **Credit Facilities:** Primary funding is sourced via **Axis Bank Ltd** through Term Loans and Working Capital loans.
* **Interest Rates:** Variable-rate borrowings are linked to **MCLR + 2.75%** (effective **11.00% p.a.**).
* **Security:** Facilities are secured by a **first charge** on current and moveable fixed assets, equitable mortgages on lands in **Uttarakhand and Haryana**, and personal guarantees from directors **Mr. K. Sayaji Rao, Mr. K. Satish Rao, and Mrs. K. Pratibha Rao**.
---
### **Governance and Leadership**
The board has been restructured to oversee the recovery phase:
* **Managing Director:** **Mr. Ketineni Satish Rao** re-appointed (2024–2029) with a monthly remuneration of **₹6,00,000** (rising to **₹7,25,000** in April 2025).
* **Board Oversight:** **Ms. Nidhi Dwarakanath** (Independent Director) serves as **Non-Executive Chairman**.
* **Audit:** M/s Lalit Sharma & Associates appointed as Secretarial Auditor for a **5-year term** starting FY 2025-26.
---
### **Risk Factors and Internal Control Deficiencies**
Investors should note several qualified opinions from auditors regarding internal controls and legal disputes.
**1. Legal and Credit Risks:**
* **Majestic Engineering Industries:** A **Rs 6.51 crore** claim was **written off** in FY 2025 after auditors questioned the probability of recovery in NCLT proceedings.
* **Maharashtra Bio Fertilizers:** A **Rs 1.41 crore** dispute remains active; the client defaulted on a previous settlement of **Rs 1.69 crore**.
* **Contingent Liabilities:** These rose sharply to **Rs 6.27 crore** as of March 31, 2025.
**2. Operational and Compliance Gaps:**
* **Labor & Wages:** The company paid **₹1.19 crore** in wages in cash (as of Dec 2025) at worker request. Outstanding bonus payments of **₹13.82 Lakhs** remain pending from previous years.
* **Record Keeping:** Auditors noted a lack of proper records for **Property, Plant and Equipment (PPE)** and a lack of physical verification for fixed assets and inventory in FY 2024-25.
* **Financial Reconciliation:** **GST Input Tax Credit (ITC)** and bank statements for limits exceeding **Rs 5 crore** are subject to reconciliation. No **Internal Audit** was conducted in FY 2024-25.
**3. Market and Macro Risks:**
* **Input Volatility:** Profitability is highly sensitive to **US Dollar** fluctuations and **petroleum prices**, which dictate the cost of raw PET/PP resins.
* **Foreign Exchange:** Currently, the company reports **zero** foreign exchange earnings and expenditure.
**Borrowing Sensitivity:**
| Particulars (₹ In Lakhs) | March 31, 2025 | March 31, 2024 |
| :--- | :--- | :--- |
| Fixed Rate Borrowings | **2,215.10** | **1,579.36** |
| Floating Rate Borrowings | **399.79** | **1,465.33** |
| **Total Borrowings** | **2,614.89** | **3,044.69** |